Status:
UNKNOWN
Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients
Lead Sponsor:
RightBio Metrics
Conditions:
Establish Normative pH Values in Neonates
Eligibility:
All Genders
24-40 years
Brief Summary
Objectives: 1. To validate the accuracy of pH measurements of gastric fluid by comparing the readings from the RightSpot Infant pH Indicator to a standard clinically approved pH monitor 2. To determi...
Detailed Description
RightBio Metrics has developed an indicator that rapidly checks gastric pH by aspirating gastric contents into the indicator through a nasogastric (NG) or orogastric (OG), causing a color change on th...
Eligibility Criteria
Inclusion
- Infants in the Newborn Intensive Care Unit with an NG Tube
Exclusion
- Infants with congenital or genetic abnormalities
- Infants with gastroschesis
- Infants with upper airway abnormalities
- Infants receiving any supplement or medication know to alter pH gastric contents
- Infants receiving Enfamil liquid human milk fortification
- Infant who are NPO status
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02279264
Start Date
September 1 2014
Last Update
October 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banner Good Samaritan
Phoenix, Arizona, United States, 85014